Juva Life Advances JUVA-019 into Preclinical Development for Inflammatory Disease

The Marijuana Times
By Juva LifeJan 10, 2022, 8:12 pm202 pts
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV), a life sciences portfolio company with operations in cannabis production and distribution as well as pharmaceutical research and development, announced Jan. 6 the advancement of their proprietary, non-cannabinoid molecule, JUVA-019, from discovery into…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Nevada opens foster parenting to those with cannabis records 41

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.